Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
How Two Companies Are Using AI to Treat Orphan Diseases
July 23, 2018
VERDICT
“FDNA has developed an app called Face2Gene, that uses facial analysis and AI to analyze features on a patient’s face, compare them with a database, and from this provide a list of possible rare diseases.”
The article discusses on leveraging artificial intelligence to tackle orphan diseases. FDNA’s Face2Gene platform is prominently featured for its innovative use of AI and facial recognition technology to diagnose rare genetic disorders, commonly termed orphan disease. Face2Gene analyzes facial features to detect subtle patterns that indicate specific genetic conditions, significantly improving diagnostic accuracy and speed. The platform aids clinicians in shortening the diagnostic journey for patients with rare diseases, paving the way for timely and personalized treatments. The article emphasizes the transformative potential of AI-driven tools like Face2Gene in revolutionizing the care for orphan disease patients.
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…